Published in BMJ on October 16, 1993
Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ (1995) 6.05
SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med (2005) 4.66
Rationing intensive care. BMJ (1995) 3.90
SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med (2005) 2.84
Assessing the quality of care. BMJ (1995) 2.72
Severe sepsis epidemiology: sampling, selection, and society. Crit Care (2004) 2.28
Reduction in mortality after inappropriate early discharge from intensive care unit: logistic regression triage model. BMJ (2001) 2.16
Safer discharge from intensive care to hospital wards. BMJ (2001) 1.79
Rationing intensive care. High dependency units may be the answer. BMJ (1995) 1.61
Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit Care (2007) 1.60
Outcomes in intensive care. BMJ (1993) 1.17
Clinical review: International comparisons in critical care - lessons learned. Crit Care (2012) 1.16
Risk adjusted and population based studies of the outcome for high risk infants in Scotland and Australia. International Neonatal Network, Scottish Neonatal Consultants, Nurses Collaborative Study Group. Arch Dis Child Fetal Neonatal Ed (2000) 1.11
Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance. Clinics (Sao Paulo) (2008) 1.04
Diagnosis based injury severity scaling: investigation of a method using Australian and New Zealand hospitalisations. Inj Prev (2004) 0.99
Performance of the score systems Acute Physiology and Chronic Health Evaluation II and III at an interdisciplinary intensive care unit, after customization. Crit Care (2001) 0.93
Process monitoring in intensive care with the use of cumulative expected minus observed mortality and risk-adjusted P charts. Crit Care (2006) 0.93
Hospital mortality of adults admitted to Intensive Care Units in hospitals with and without Intermediate Care Units: a multicentre European cohort study. Crit Care (2014) 0.90
High dependency units in the UK: variable size, variable character, few in number. Postgrad Med J (1995) 0.84
External validation of the Intensive Care National Audit & Research Centre (ICNARC) risk prediction model in critical care units in Scotland. BMC Anesthesiol (2014) 0.82
The clinical efficacy of GOCA scoring system in patients with acute respiratory distress syndrome. J Korean Med Sci (2008) 0.80
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis (2002) 0.79
Who Dies after ICU Discharge? Retrospective Analysis of Prognostic Factors for In-Hospital Mortality of ICU Survivors. J Korean Med Sci (2017) 0.75
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol (1982) 11.13
An evaluation of outcome from intensive care in major medical centers. Ann Intern Med (1986) 5.41
Assessment of prediction of mortality by using the APACHE II scoring system in intensive-care units;. Mayo Clin Proc (1990) 1.79
An initial comparison of intensive care in Japan and the United States. Crit Care Med (1992) 1.79
Patient selection for intensive care: a comparison of New Zealand and United States hospitals. Crit Care Med (1988) 1.34
Audit in intensive care. The APACHE II classification of severity of disease. Ulster Med J (1990) 1.13
Acute physiology and chronic health evaluation (APACHE II) scoring in a cardiothoracic intensive care unit. Crit Care Med (1991) 1.10
Severity of disease classification system. Crit Care Med (1991) 1.02
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med (1982) 12.33
Confidential inquiry into quality of care before admission to intensive care. BMJ (1998) 11.32
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J (1968) 11.26
Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J (1970) 6.82
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ (1997) 6.32
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Increasing use of private practice by patients in Oxford requiring common elective surgical operations. Br Med J (Clin Res Ed) (1985) 5.49
Statistics: the problem of examining accumulating data more than once. N Engl J Med (1974) 5.09
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
Regional variations in the use of common surgical procedures: within and between England and Wales, Canada and the United States of America. Soc Sci Med A (1981) 4.88
Rising incidence of fracture of the proximal femur. Lancet (1985) 4.83
Relation between general practices' outpatient referral rates and rates of elective admission to hospital. BMJ (1990) 4.66
Mortality among appropriately referred patients refused admission to intensive-care units. Lancet (1997) 4.65
Will payment based on diagnosis-related groups control hospital costs? N Engl J Med (1984) 4.56
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50
Diagnostic dilatation and curettage: is it used appropriately? BMJ (1993) 4.28
Breast cancer and hormonal supplements in postmenopausal women. BMJ (1995) 4.16
A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med (1989) 3.97
Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ (1999) 3.96
Third generation oral contraception and venous thromboembolism. BMJ (1996) 3.76
Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet (1983) 3.53
The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract (2001) 3.48
Socioeconomic variations in the use of common surgical operations. Br Med J (Clin Res Ed) (1985) 3.46
Do British women undergo too many or too few hysterectomies? Soc Sci Med (1988) 3.45
Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy (1999) 3.23
Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J (1978) 3.20
Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet (1968) 3.18
Ratio of waist circumference to height may be better indicator of need for weight management. BMJ (1996) 3.17
The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer (1988) 3.07
The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol (1992) 2.99
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med (1998) 2.99
A randomised controlled trial of surgery for glue ear. BMJ (1990) 2.93
Risk of venous thromboembolism in users of hormone replacement therapy. Lancet (1996) 2.92
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) (1983) 2.90
Removing barriers to career development in public health. BMJ (2000) 2.82
Oral contraceptives and breast neoplasia: a retrospective study. Br Med J (1972) 2.81
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. BMJ (1994) 2.70
Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet (1981) 2.63
Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ (1997) 2.61
Response of women aged 65-74 to invitation for screening for breast cancer by mammography: a pilot study in London, UK. J Epidemiol Community Health (1996) 2.61
Outcome of pregnancy in women using an intrauterine device. Lancet (1974) 2.58
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
For and against: Public health does not need to be led by doctors. For. BMJ (2001) 2.57
Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract (1995) 2.56
Reduction in total under-five mortality in western Nepal through community-based antimicrobial treatment of pneumonia. Lancet (1991) 2.54
Familial breast cancer. BMJ (1994) 2.54
Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess (1998) 2.49
The frequency distributions of commonly determined blood constituents in healthy blood donors. Clin Chim Acta (1974) 2.49
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Symptomless diverticular disease and intake of dietary fibre. Lancet (1979) 2.45
Measuring the impact of menopausal symptoms on quality of life. BMJ (1993) 2.42
An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA (1988) 2.42
Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol (1990) 2.41
Fertility after stopping different methods of contraception. Br Med J (1978) 2.40
Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) (1982) 2.40
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Utilisation of hormone replacement therapy by women doctors. BMJ (1995) 2.35
Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer (1987) 2.35
Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol (1987) 2.34
Mortality of gasworkers - final report of a prospective study. Br J Ind Med (1972) 2.31
Study of symptoms in middle life with special reference to the menopause. Br Med J (1980) 2.24
Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception (1987) 2.21
Teenagers and their health. Arch Dis Child (1987) 2.20
The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review. Br J Obstet Gynaecol (1998) 2.18
Preliminary evaluation of four oral contraceptives containing only progestogens. Br Med J (1969) 2.16
Oral contraceptives and breast cancer. Lancet (1983) 2.16
Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev (2001) 2.14
HRT: an analysis of benefits, risks and costs. Br Med Bull (1992) 2.11
Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health (1997) 2.08
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med (1985) 2.07
Postoperative thromboembolism and the use of oral contraceptives. Br Med J (1970) 2.04
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
Chronic pelvic pain in the community--symptoms, investigations, and diagnoses. Am J Obstet Gynecol (2001) 2.01
Treatment of sympathetic overactivity in tetanus. Lancet (1969) 1.98
Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol (1992) 1.97
Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet (1997) 1.95
Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J (Clin Res Ed) (1987) 1.91
Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer (1982) 1.90
Dietary intake and plasma lipid levels: lessons from a study of the diet of health conscious groups. BMJ (1990) 1.88
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88